| Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV … AC Hearps, D Tyssen, D Srbinovski, L Bayigga, DJD Diaz, M Aldunate, ... Mucosal immunology 10 (6), 1480-1490, 2017 | 193 | 2017 |
| Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention L Bayigga, DP Kateete, DJ Anderson, M Sekikubo, D Nakanjako American journal of obstetrics and gynecology 220 (2), 155-166, 2019 | 80 | 2019 |
| Atorvastatin reduces T‐cell activation and exhaustion among HIV‐infected c ART‐treated suboptimal immune responders in U ganda: a randomised crossover placebo‐controlled trial D Nakanjako, I Ssinabulya, R Nabatanzi, L Bayigga, A Kiragga, M Joloba, ... Tropical medicine & international health 20 (3), 380-390, 2015 | 59 | 2015 |
| Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort R Nabatanzi, L Bayigga, S Cose, S Rowland-Jones, G Canderan, ... Clinical Immunology 201, 55-60, 2019 | 42 | 2019 |
| Monocyte dysfunction, activation, and inflammation after long-term antiretroviral therapy in an African cohort R Nabatanzi, L Bayigga, S Cose, S Rowland Jones, M Joloba, ... The Journal of infectious diseases 220 (9), 1414-1419, 2019 | 27 | 2019 |
| High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV … L Bayigga, R Nabatanzi, PN Sekiziyivu, H Mayanja-Kizza, MR Kamya, ... BMC immunology 15, 1-8, 2014 | 22 | 2014 |
| Towards access for all: 1st working group report for the global gene therapy initiative (GGTI) JE Adair, L Androski, L Bayigga, D Bazira, E Brandon, L Dee, S Deeks, ... Gene Therapy 30 (3), 216-221, 2023 | 17 | 2023 |
| Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort R Nabatanzi, L Bayigga, I Ssinabulya, A Kiragga, A Kambugu, J Olobo, ... Immunology letters 162 (2), 264-272, 2014 | 16 | 2014 |
| CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda D Nakanjako, J Otiti-Sengeri, I Ssewanyana, R Nabatanzi, L Bayigga, ... Immunology letters 161 (1), 44-49, 2014 | 13 | 2014 |
| Diverse vaginal microbiome was associated with pro-inflammatory vaginal milieu among pregnant women in Uganda L Bayigga, R Nabatanzi, A Ssekagiri, DP Kateete, M Sekikubo, ... Human Microbiome Journal 18, 100076, 2020 | 12 | 2020 |
| Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort R Nabatanzi, L Bayigga, S Cose, G Canderan, S Rowland Jones, ... BMC immunology 22 (1), 59, 2021 | 9 | 2021 |
| Sero-diagnosis of active Mycobacterium tuberculosis disease among HIV co-infected persons using thymidylate kinase based antigen and antibody capture enzyme immuno-assays M Wayengera, I Mwebaza, J Welishe, C Nakimuli, DP Kateete, ... Mycobacterial diseases: tuberculosis & leprosy 7 (2), 2017 | 9 | 2017 |
| Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV … AC Hearps, D Tyssen, D Srbinovski, L Bayigga, DJD Diaz, M Aldunate, ... | 9 | 2017 |
| Place-of-care manufacturing of gene therapies JE Adair, K Anthony-Gonda, L Bayigga, R Orentas, CK Mutuluuza, ... The Lancet Haematology 9 (11), e807-e808, 2022 | 1 | 2022 |
| Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI) JE Adair, L Androski, L Bayigga, D Bazira, E Brandon, L Dee, S Deeks, ... Gene Therapy 30 (3-4), 405, 2023 | | 2023 |
| Role of vaginal microbiome in host susceptibility to HIV infection among pregnant Ugandan women: inflammatory response and epithelial barrier integrity L Bayigga Makerere University, 2021 | | 2021 |
| Monocyte dysfunction, immune activation and inflammation after long-term antiretroviral therapy in an African cohort R Nabatanzi, S Cose, SR Jones, M Joloba, L Bayigga, D Nakanjako Open Res Africa 2 (127), 127, 2019 | | 2019 |
| Host immune recovery during long-term anti-retroviral therapy D Nakanjako, R Nabatanzi, L Bayigga, SR Jones, S Cose Open Res Africa 2 (62), 62, 2019 | | 2019 |
| LB1. 68 Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated … G Tachedjian, H Ac, D Tyssen, D Srbinosvki, L Bayigga, D Djd, ... Sexually Transmitted Infections 93 (Suppl 2), A69-A69, 2017 | | 2017 |
| Safety and Efficacy Assessment of VRCO1-N and MB66 Microbicide Film in an in Vitro Vaginal Environment GB Vaca, L Bayigga, J Marathe, J Politch, M Sagar, K Whaley, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 215-215, 2016 | | 2016 |
